Literature DB >> 2432977

Pharmacological analysis of the interaction between Bay K 8644 and 5-HT in rabbit aorta.

V J Barrett, P Leff, G R Martin, P J Richardson.   

Abstract

Bay K 8644 potentiated and augmented 5-hydroxytryptamine (5-HT)-induced contractions in the rabbit, isolated aorta preparation, as manifested in leftward shift and increase in the asymptote of 5-HT E/[A] (effect vs concentration) curves. The operational model of agonism (Black & Leff, 1983) was used to analyse this interaction and the concomitant effects of irreversible receptor alkylation by phenoxybenzamine. The competitive effects of spiperone in the presence and absence of Bay K 8644 were also examined. From these analyses it is concluded that Bay K 8644 elicits its potentiating effects by increasing the efficacy of 5-HT at the 5-HT2 receptor with no alteration in affinity. This is consistent with the known effect of Bay K 8644 of causing an increase in the functional concentration of plasmalemmal calcium channels coupled to the 5-HT2 receptors in this preparation. The positively co-operative shape of the 5-HT E/[A] curves obtained in the aorta and the quantitative nature of their potentiation by Bay K 8644 indicated that the coupling of 5-HT2 receptor occupancy to intracellular calcium concentration is linear and that the co-operativity resides in the subsequent relation between intracellular calcium and pharmacological effect. Bay K 8644 may serve as a probe for differentiating between the types of calcium channels that transduce 5-HT receptor-mediated effects in different systems. Such information would be useful in the classification of agonist interactions with 5-HT receptors.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2432977      PMCID: PMC1916559          DOI: 10.1111/j.1476-5381.1986.tb10190.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  21 in total

1.  A modification of receptor theory.

Authors:  R P STEPHENSON
Journal:  Br J Pharmacol Chemother       Date:  1956-12

2.  Calcium requirement for activation of intact aortic smooth muscle.

Authors:  C Van Breemen
Journal:  J Physiol       Date:  1977-11       Impact factor: 5.182

3.  The influence of calcium on the activity of full and partial muscarinic agonists.

Authors:  J M Gião; T Rico
Journal:  Eur J Pharmacol       Date:  1971-01       Impact factor: 4.432

4.  Ketanserin--a novel antihypertensive drug?

Authors:  P P Humphrey; W Feniuk; A D Watts
Journal:  J Pharm Pharmacol       Date:  1982-08       Impact factor: 3.765

5.  Is prenalterol (H133/80) really a selective beta 1 adrenoceptor agonist? Tissue selectivity resulting from differences in stimulus-response relationships.

Authors:  T P Kenakin; D Beek
Journal:  J Pharmacol Exp Ther       Date:  1980-05       Impact factor: 4.030

6.  Novel dihydropyridines with positive inotropic action through activation of Ca2+ channels.

Authors:  M Schramm; G Thomas; R Towart; G Franckowiak
Journal:  Nature       Date:  1983 Jun 9-15       Impact factor: 49.962

7.  Use of selective antagonists for determining the types of receptors mediating the actions of 5-hydroxytryptamine and tryptamine in the isolated rabbit aorta.

Authors:  J S Stollak; R F Furchgott
Journal:  J Pharmacol Exp Ther       Date:  1983-01       Impact factor: 4.030

8.  Selectivity of calcium antagonism and serotonin antagonism with respect to venous and arterial tissues.

Authors:  J M Van Nueten; P M Vanhoutte
Journal:  Angiology       Date:  1981-07       Impact factor: 3.619

9.  Evidence that blood pressure reduction by serotonin antagonists is related to alpha receptor blockade in spontaneously hypertensive rats.

Authors:  M L Cohen; R W Fuller; K D Kurz
Journal:  Hypertension       Date:  1983 Sep-Oct       Impact factor: 10.190

10.  Mechanism of 5-HT contraction in isolated bovine ventricular coronary arteries. Evidence for transient receptor-operated calcium influx channels.

Authors:  P H Ratz; S F Flaim
Journal:  Circ Res       Date:  1984-02       Impact factor: 17.367

View more
  6 in total

1.  Pharmacological analysis of the calcium-dependence of mu-receptor agonism.

Authors:  I G Dougall; P Leff
Journal:  Br J Pharmacol       Date:  1987-12       Impact factor: 8.739

2.  Comparative analysis of two types of 5-hydroxytryptamine receptor mediating vasorelaxation: differential classification using tryptamines.

Authors:  G R Martin; P Leff; D Cambridge; V J Barrett
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-10       Impact factor: 3.000

3.  Modelling the changes induced by chronic desipramine treatment on the factors governing the agonism at prejunctional alpha 2-adrenoceptors.

Authors:  J Sallés; J Giraldo; E Vila; A Badia
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

4.  The classification of peripheral 5-HT2-like receptors using tryptamine agonist and antagonist analogues.

Authors:  P Leff; G R Martin; J M Morse
Journal:  Br J Pharmacol       Date:  1986-11       Impact factor: 8.739

5.  Differential classification of vascular smooth muscle and endothelial cell 5-HT receptors by use of tryptamine analogues.

Authors:  P Leff; G R Martin; J M Morse
Journal:  Br J Pharmacol       Date:  1987-06       Impact factor: 8.739

6.  Potentiation by endothelin-1 of 5-hydroxytryptamine-induced contraction in coronary artery of the pig.

Authors:  K Nakayama; Y Ishigai; H Uchida; Y Tanaka
Journal:  Br J Pharmacol       Date:  1991-12       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.